|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07F 5/02 | (2006.01) |
| C07F 5/04 | (2006.01) |
| (11) | Number of the document | 2377869 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11167264.8 |
| Date of filing the European patent application | 2005-03-24 | |
| (97) | Date of publication of the European application | 2011-10-19 |
| (45) | Date of publication and mention of the grant of the patent | 2014-01-29 |
| (46) | Date of publication of the claims translation | 2014-05-26 |
| (30) | Number | Date | Country code |
| 557535 P | 2004-03-30 | US |
| (72) |
Pickersgill, I. Fraser, US
Bishop, John, US
Ammoscato, Vince, US
Munk, Stephen, US
Lo, Young, US
Chiu, Fang-Ting, US
Kulkarni, Vithalanand R., US
|
| (73) |
MILLENNIUM PHARMACEUTICALS, INC.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Bortezomibo sintezė |
| Synthesis of Bortezomib |
| Payment date | Validity (years) | Amount | |
| 2024-02-20 | 347.00 EUR |